Cargando…

Glycans as Targets for Drug Delivery in Cancer

SIMPLE SUMMARY: Alterations in glycosylation are frequently observed in cancer cells. Different strategies have been proposed to increase drug delivery to the tumor site in order to improve the therapeutic efficacy of anti-cancer drugs and avoid collateral cytotoxicity. The exploitation of drug deli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diniz, Francisca, Coelho, Pedro, Duarte, Henrique O., Sarmento, Bruno, Reis, Celso A., Gomes, Joana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870586/ https://www.ncbi.nlm.nih.gov/pubmed/35205658 http://dx.doi.org/10.3390/cancers14040911

Ejemplares similares

Polymeric nanoparticles targeting Sialyl-Tn in gastric cancer: A live tracking under flow conditions
por: Diniz, Francisca, et al.
Publicado: (2022)

Differential Protein and Glycan Packaging into Extracellular Vesicles in Response to 3D Gastric Cancer Cellular Organization
por: Martins, Álvaro M., et al.
Publicado: (2023)

Mucin-Type O-Glycosylation in Gastric Carcinogenesis
por: Duarte, Henrique O., et al.
Publicado: (2016)

Expression of Thomsen–Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability
por: Leão, Beatriz, et al.
Publicado: (2021)

Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system
por: Gomes, Maria João, et al.
Publicado: (2014)

Gastric Cancer Cell Glycosylation as a Modulator of the ErbB2 Oncogenic Receptor
por: Duarte, Henrique O., et al.
Publicado: (2017)

O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype
por: Freitas, Daniela, et al.
Publicado: (2019)

Impact of Truncated O-glycans in Gastric-Cancer-Associated CD44v9 Detection
por: Moreira, Inês B., et al.
Publicado: (2020)

Editorial: Glycans: Masters of immunity, from cancers to inflammatory disease
por: Beatson, Richard, et al.
Publicado: (2022)

Targeting the glycans: A paradigm for host‐targeted and COVID‐19 drug design
por: Pourrajab, Fatemeh
Publicado: (2021)

Mucin Glycans: A Target for Cancer Therapy
por: Sun, Lingbo, et al.
Publicado: (2023)

Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection
por: Pinho, Salomé S., et al.
Publicado: (2023)

Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
por: Cunha, Andrea, et al.
Publicado: (2023)

Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer
por: Mereiter, Stefan, et al.
Publicado: (2016)

Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
por: Berois, Nora, et al.
Publicado: (2022)

Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems
por: Viegas, Cláudia, et al.
Publicado: (2023)

Glycans in drug discovery
por: Valverde, Pablo, et al.
Publicado: (2019)

Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
por: Yu, Yingyan, et al.
Publicado: (2023)

Glycans as Biomarkers in Prostate Cancer
por: Scott, Emma, et al.
Publicado: (2019)

Targeted Drug Delivery for the Treatment of Blood Cancers
por: Jiang, Yao, et al.
Publicado: (2022)

Sequential Drug Delivery in Targeted Cancer Therapy
por: Yu, Han, et al.
Publicado: (2022)

Nanocarrier-Mediated Topical Insulin Delivery for Wound Healing
por: Macedo, Ana S., et al.
Publicado: (2021)

Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging
por: Houvast, Ruben D., et al.
Publicado: (2020)

The role of glycans in the mechanobiology of cancer
por: Purushothaman, Anurag, et al.
Publicado: (2023)

Cancer cell associated glycans as targets for immunotherapy
por: Vankemmelbeke, Mireille, et al.
Publicado: (2015)

Glycan Nanobiosensors
por: Kveton, Filip, et al.
Publicado: (2020)

Aptamers for Targeted Drug Delivery
por: Ray, Partha, et al.
Publicado: (2010)

Riboflavin-Targeted Drug Delivery
por: Darguzyte, Milita, et al.
Publicado: (2020)

Glycan Analysis as Biomarkers for Testicular Cancer
por: Hires, Michal, et al.
Publicado: (2019)

Biointerface engineering nanoplatforms for cancer-targeted drug delivery
por: Zhang, Huaiyu, et al.
Publicado: (2020)

Targeted drug delivery for cancer therapy: the other side of antibodies
por: Firer, Michael A, et al.
Publicado: (2012)

Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment
por: Gierlich, Piotr, et al.
Publicado: (2020)

Adhesion of Helicobacter Species to the Human Gastric Mucosa: A Deep Look Into Glycans Role
por: Matos, Rita, et al.
Publicado: (2021)

Pore forming channels as a drug delivery system for photodynamic therapy in cancer associated with nanoscintillators
por: Alves, Luiz Anastacio, et al.
Publicado: (2018)

Glycans and Glycan-Binding Proteins as Regulators and Potential Targets in Leukocyte Recruitment
por: Krautter, Franziska, et al.
Publicado: (2021)

ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab
por: Duarte, Henrique O., et al.
Publicado: (2021)

Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans
por: Pashov, Anastas, et al.
Publicado: (2010)

Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment
por: Massey, Andrew E., et al.
Publicado: (2021)

Multicellular Human Gastric Cancer Spheroids Mimic the Glycosylation Phenotype of Gastric Carcinomas
por: Balmaña, Meritxell, et al.
Publicado: (2018)

The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
por: Smith, Benjamin A. H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mu4grf3akh5q2sarbui8hhvi88